These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3161617)

  • 1. [Ketanserin in the treatment of ischemic disease of the lower extremities].
    Gerová Z; Brimichová E; Dzúrik R
    Cas Lek Cesk; 1985 Jul; 124(30):938-41. PubMed ID: 3161617
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra arterial ketanserin in peripheral vascular disease.
    Boas RA
    Angiology; 1986 Apr; 37(4):267-71. PubMed ID: 2940946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous imaging of regional blood flow in peripheral vascular disease using Krypton-81m: effect of Ketanserin, a new selective serotonin antagonist.
    Gerritsen HA; Perquin JW; de Smet HL; Troost FA; Kotora OV
    Diagn Imaging; 1983; 52(2-3):85-92. PubMed ID: 6851822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of betalytics on blood circulation in the extremities of patients with lower extremity ischemic disease].
    Spácil J
    Cas Lek Cesk; 1987 May; 126(19):600-4. PubMed ID: 2885093
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.
    Stranden E; Roald OK; Krohg K
    Br Med J (Clin Res Ed); 1982 Oct; 285(6348):1069-71. PubMed ID: 6812750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study with the competitive 5-HT2-serotonergic antagonist ketanserin.
    Ferrara LA; Fasano ML; Rubba P; Soro S; Marotta G; Mancini M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S159-60. PubMed ID: 2412041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ketanserin in ischemic disease of the lower extremities. Results of a double-blind cross-over study].
    Broulíková A; Linhart J
    Cas Lek Cesk; 1987 Sep; 126(35-36):1094-6. PubMed ID: 3311372
    [No Abstract]   [Full Text] [Related]  

  • 8. Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudication.
    Bounameaux H; Holditch T; Hellemans H; Berent A; Verhaeghe R
    Lancet; 1985 Dec; 2(8467):1268-71. PubMed ID: 2866336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
    Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G
    Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of serotonin and its antagonists in anesthetic and surgical stress].
    Carrasco MS; de Castro J; Arroyo JL
    Rev Esp Anestesiol Reanim; 1983; 30(2):65-8. PubMed ID: 6878802
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exercise therapy (kinesiotherapy) of stage 3 ischemic disease of the lower extremities].
    Gavorník P; Kolesár J; Dukát A
    Vnitr Lek; 1986 Jun; 32(6):597-604. PubMed ID: 3739252
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute effects of antagonist of S2-receptors.
    Petkovská N; Brimichová G; Tison P; Dzúrik R
    Czech Med; 1984; 7(4):210-4. PubMed ID: 6084584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does ketanserin relieve frostbite?
    Vayssairat M; Priollet P; Hagege A; Housset E; Foray J
    Practitioner; 1986 May; 230(1415):406-8. PubMed ID: 2944086
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of serotonin-receptor blockade after cardiopulmonary by-pass. A pilot study.
    Miranda DR; Stoutenbeek CP; Zandstra D; Alexander JP
    Acta Anaesthesiol Belg; 1982; 33(1):63-8. PubMed ID: 7090727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood flow in subcutaneous tissue in ischemic disease of the lower extremities and in controls during slow walking].
    Spácil J; Hlavová A; Linhart J; Prerovský I
    Vnitr Lek; 1980 Jan; 26(1):31-7. PubMed ID: 7355584
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical significance of serotonin antagonists].
    Regenthal R; Voigt H
    Z Gesamte Inn Med; 1989 Sep; 44(17):504-8. PubMed ID: 2686226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandin E1 in treatment of incomplete ischemia syndromes of the lower extremity].
    Vogelpohl M; Nobbe F
    Vasa Suppl; 1991; 32():377-82. PubMed ID: 1771539
    [No Abstract]   [Full Text] [Related]  

  • 20. Is prevention of hypertension after open heart surgery possible by blocking 5HT2-receptors with ketanserin?
    van den Broeke JJ; Karliczek GF; Brenken U; Schokkenbroek R; Homan van der Heide JN
    Acta Anaesthesiol Belg; 1982; 33(2):115-20. PubMed ID: 6981913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.